It is the object underlying the present invention to provide compounds, compositions and formulations that are useful for the treatment of parasitic diseases caused by a parasite species selected from the list consisting of the following genders: Leishmania, Trypanosome or Plasmodium, in particular selected from the following species: Leishmania donovani, Trypanosoma cruzi, Trypanosoma Brucei and Plasmodium falciparum.